IP Library Granted Patent US 7,858,079
Granted Patent B2
US 7,858,079 · App. 11/712,333 · Granted Dec 28, 2010

Tissue adhesives and sealants and method for their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,079
App. No.
11/712,333
Granted
Dec 28, 2010
Kind
B2
Abstract

Compositions provided by mixing a biotin-containing component and an avidin-containing component are useful as an adhesive or sealant for medical/surgical uses.

Claims (21)

1. A biocompatible composition comprising:

a biocompatible biotin-containing component comprising a first polymer selected from the group consisting of polyethylene glycols and absorbable polymers, wherein the first polymer is functionalized with biotin; and

a biocompatible avidin-containing component comprising a second polymer selected from the group consisting of polyethylene glycols and absorbable polymers, wherein the second polymer is functionalized with avidin or streptavidin,

wherein the composition is suitable for in vivo contact with tissue, wherein at least the first polymer or the second polymer is an absorbable polymer selected from the group consisting of polycaprolactone, poly-D,L-lactic acid, poly-L-lactic acid, poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polydioxanone, polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolic acid-cotrimethylene carbonate), polyphosphoester, polyphosphoester urethane, polyglutamic acid, polyaspartic acid, absorbable cyanoacrylates, poly(trimethylene carbonate), copoly(ether-esters), polyalkylene oxalates, polyphosphazenes, polyiminocarbonates, aliphatic polycarbonates, and combinations thereof, and wherein the biotin-containing component and the avidin-containing component form a gel matrix when the two components are combined.

2. The biocompatible composition as in claim 1 , wherein the biocompatible biotin-containing component comprises polyethylene glycol, and wherein the biotin-containing component has a molecular weight of from about 500 Daltons to about 5,000 Daltons.

3. The biocompatible composition as in claim 1 , wherein the second polymer is functionalized with avidin.

4. The A biocompatible composition as in claim 1 , wherein the second polymer is functionalized with streptavidin.

5. The biocompatible composition as in claim 1 , wherein the biocompatible composition further comprises a bioactive agent.

6. A method for adhering tissue comprising:

approximating a first tissue surface and a second tissue surface; and

applying the biocompatible composition of claim 1 to the approximated first and second tissue surfaces to adhere the first tissue surface to the a second tissue surface.

7. A method for adhering a medical device to a tissue surface, the method comprising:

approximating a medical device and a tissue surface; and

applying the biocompatible composition of claim 1 to the medical device, to the tissue surface, or both,

wherein applying the biocompatible composition adheres the medical device to the tissue surface.

8. A biocompatible composition comprising:

a biocompatible biotin-containing component comprising a first polymer, wherein the first polymer is functionalized with biotin; and

a biocompatible avidin-containing component comprising a second polymer, wherein the second polymer is functionalized with avidin or streptavidin,

wherein the first polymer, the second polymer, or both, is selected from the group consisting of polycaprolactone, poly-D,L-lactic acid, poly-L-lactic acid, poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polydioxanone, polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolic acid-cotrimethylene carbonate), polyphosphoester, polyphosphoester urethane, polyglutamic acid, polyaspartic acid, absorbable cyanoacrylates, poly(trimethylene carbonate), copoly(ether-esters), polyalkylene oxalates, polyphosphazenes, polyiminocarbonates, aliphatic polycarbonates, and combinations thereof,

wherein the composition is suitable for in vivo contact with tissue, and

wherein the biotin-containing component and the avidin-containing component form a gel matrix when the two components are combined.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: HADBA, AHMAD R.; STOPEK, JOSHUA B.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 019291/0018 →